AACR
5 kwietnia 2014
AACR Annual Meeting 2014, 5-9 April 2014, San Diego, USA:
Rok
2014
Cel
PIM/FLT3, MNK, daposertib (MEN1703 / SEL24)
Zasoby na tej stronie
Pobierz zasoby
- plik pdf
“Preclinical characterization of SEL24-B489, a dual PIM/FLT3 inhibitor for the treatment of hematological malignancies”
Pobierz - plik pdf
“Repression of tumor survival pathways by novel, selective inhibitors of MNK1 and MNK2 kinases”
Pobierz